Vanderbilt Heart and Vascular Institute Archives
Lindley named to direct new multidisciplinary Women’s Heart Center
Aug. 17, 2022—Kathryn Lindley, MD, has joined the Vanderbilt Heart and Vascular Institute as director of the new Women’s Heart Center.
VUMC mourns loss of noted cardiologist Page
Aug. 3, 2022—Harry Lee Page Jr., MD, a pioneer of modern cardiology and a presence at Vanderbilt for decades, died Aug. 1 after a long illness.
VWCH relaunches interventional cardiology program
Aug. 1, 2022—Vanderbilt Wilson County Hospital has launched a percutaneous coronary intervention program to treat patients diagnosed with heart attacks and coronary artery disease.
Patient doing well after complex vascular procedures
Jul. 28, 2022—Marsha Eastridge had no clue she had heart problems until she was diagnosed in December 2021. Barely three weeks later, she was undergoing the first of two complex vascular procedures at Vanderbilt Heart and Vascular Institute that would save her life.
Chest Pain Center receives reaccreditation from ACC
Mar. 3, 2022—Vanderbilt University Medical Center has been reaccredited as a Chest Pain Center with Primary Percutaneous Coronary Intervention (PCI) and Resuscitation.
Wear Red Day
Feb. 10, 2022—Members of Vanderbilt Heart and Vascular Institute (VHVI) gathered for a photo last week to recognize National Wear Red Day — an observance created by the American Heart Association and the National Heart, Lung and Blood Institute to raise awareness of heart disease, which is the leading cause of death in the United States.
VUMC lauded for hypertrophic cardiomyopathy care
Oct. 21, 2021—Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.
VHVI reaches milestone in cardiac monitor implants
Sep. 15, 2021—Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.
VHVI offers latest therapies to treat atrial fibrillation
Sep. 9, 2021—Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.
Novel LVAD allows patient to see family, celebrate milestones
Sep. 2, 2021—Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.
Structural Heart and Valve Center reaches procedure milestones
Aug. 12, 2021—The Structural Heart and Valve Center at Vanderbilt Heart and Vascular Institute (VHVI) has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves, a continuation of a decade of research that is revolutionizing the treatment of these conditions.
Anticoagulation Clinic at Vanderbilt Heart designated an Anticoagulation Center of Excellence
Jun. 9, 2021—The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.
